Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Elevation Oncology Q3 EPS $(1.67) Down From $(0.53) YoY

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(1.67) per share. This is a 215.09 percent decrease over losses of $(0.53) per share from the same period last year.
byBenzinga Newsdesk
November 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(1.67) per share. This is a 215.09 percent decrease over losses of $(0.53) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts